Study of acylhydrazone derivatives with deoxygenated seven-membered rings as potential β-ketoacyl-acyl carrier protein synthase III (FabH) inhibitors

MedChemComm
2016.0

Abstract

Fatty acid biosynthesis is essential for bacterial survival. FabH, β-ketoacyl-acyl carrier protein (ACP) synthase III, is a particularly attractive target, since it is central to the initiation of fatty acid biosynthesis and highly conserved among Gram-positive and Gram-negative bacteria. Following previous studies, a series of acylhydrazone derivatives with deoxygenated rings were synthesized in this work. For all of the 36 analogues synthesized, studies using H NMR, C NMR, MS and elemental analyses were conducted. Their biological activities were also evaluated against two Gram-negative bacterial strains: E. coli and P. aeruginosa, and two Gram-positive bacterial strains: B. subtilis and S. aureus by the MTT method as potential FabH inhibitors. The resulting compound F18 showed the highest antibacterial activity with MIC values of 1.56–3.13 μg mL−1 against the tested bacterial strains and was found to be the most potent E. coli FabH inhibitor with an IC50 value of 2.0 μM. Molecular modeling simulation studies were performed in order to predict the biological activities of compound F18 into the E. coli FabH active site.

Knowledge Graph

Similar Paper

Study of acylhydrazone derivatives with deoxygenated seven-membered rings as potential β-ketoacyl-acyl carrier protein synthase III (FabH) inhibitors
MedChemComm 2016.0
Design, synthesis, and structure–activity relationships of pyrazole derivatives as potential FabH inhibitors
Bioorganic & Medicinal Chemistry Letters 2010.0
Design, synthesis and biological evaluation of novel thiazole derivatives as potent FabH inhibitors
Bioorganic & Medicinal Chemistry Letters 2009.0
Discovery of vinylogous carbamates as a novel class of β-ketoacyl-acyl carrier protein synthase III (FabH) inhibitors
Bioorganic & Medicinal Chemistry 2011.0
Design, synthesis and antimicrobial activities evaluation of Schiff base derived from secnidazole derivatives as potential FabH inhibitors
Bioorganic & Medicinal Chemistry 2013.0
Synthesis, molecular modeling and biological evaluation of β-ketoacyl-acyl carrier protein synthase III (FabH) as novel antibacterial agents
Bioorganic & Medicinal Chemistry 2011.0
Design, synthesis and biological evaluation of urea derivatives from o-hydroxybenzylamines and phenylisocyanate as potential FabH inhibitors
Bioorganic & Medicinal Chemistry 2011.0
Design and synthesis of potent inhibitors of β-ketoacyl-acyl carrier protein synthase III (FabH) as potential antibacterial agents
European Journal of Medicinal Chemistry 2010.0
Design, synthesis and antibacterial activities of 5-(pyrazin-2-yl)-4H-1,2,4-triazole-3-thiol derivatives containing Schiff base formation as FabH inhibitory
Bioorganic & Medicinal Chemistry Letters 2014.0
Design and synthesis of novel deoxybenzoin derivatives as FabH inhibitors and anti-inflammatory agents
Bioorganic & Medicinal Chemistry Letters 2010.0